Seattle researchers uncover genetic drivers of aggressive prostate cancer; NCI awards $200K contract to BioMarker Strategies

> Researchers from the Fred Hutchinson Cancer Research Center and the University of Washington have found genetic triggers at play in aggressive forms of prostate cancer. Story

> The National Cancer Institute has awarded a $200,000 contract to BioMarker Strategies to fund the creation of a companion molecular diagnostic to match patients with the appropriate targeted cancer drugs. Report

> Researchers at the University of Cambridge have identified genes that could be used to guide treatment of patients with Crohn disease and ulcerative colitis. Item

> A group of scientists from UCLA and elsewhere have contributed to the discovery of gene variants that signal increased risk of schizophrenia and bipolar disorder. Release

Suggested Articles

Abbott launched a rapid coronavirus test able to deliver positive results in as little as five minutes, from a table-top box the size of a toaster.

The FDA will be working with government and public-private partners to distribute and evaluate 3D designs and models.

The FDA issued a wide-ranging emergency policy allowing alternative devices to be used as potentially lifesaving ventilators amid new shortages.